Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 197.62

+0.1%

12:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Proton who wrote (13635)	1/23/1998 1:22:00 AM
From: Andrew H	Read Replies (3) of 32384

>>What you and Henry have said makes sense. I wonder if LGND shareholders will avoid a knee-jerk reaction.<< Its an interesting question, Peter. I remember when they came out with some P2 results on Panretin and mentioned it looked good for a couple of indications and not so good for others--there was a brief and mild sell off after which it soon rebounded. Panretin is of course far more relevant to LGND's future than droloxifene (although if it were to become a billion dollar osteo drug, it could be significant at 3%). LGND has so many drugs in so many trials for so many indications that I find it hard to worry about something like this, especially when LGND has said the drug looks better for osteo. They will be getting their milestones in any case. I guess LGND could put out a release, but this seems so small in regard to their overall program, I suspect they will not comment.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next